can you take semaglutide if you had thyroid cancer and New study finds weight loss

140 In contrast, growth of the CT-2A Astrocytoma in these mice was not influenced by an unrestricted KD containing 17E% protein, 141 but significantly reduced on a calorically restricted KD containing only 8E% protein, along with significant reductions in blood glucose and IGF-1

10.1186/1741-7015-11-154 21 LiD.ZhengL.ZhaoD.XuY.WangY

For individuals with diabetes and overweight or obesity, the ADA recommends as preferred pharmacotherapy a GLP-1 receptor agonist or a dual GLP-1/GIP receptor agonist with substantial weight-loss efficacy, meaning semaglutide or tirzepatide

Tips for managing side effects when switching If you switch GLP-1 medications, you may experience gastrointestinal side effects such as nausea, diarrhea, stomach pain, appetite reduction, constipation, bloating, and excessive burping

A quick rule of thumb: color and shape narrow the field, but the imprint code is the definitive identifier

Inflammatory markers: C-reactive protein and other inflammation indicators typically decrease